Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-11 Purchase |
2023-09-12 6:23 pm |
Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC Chief Financial Officer |
10,000 | $29.65 | $296,492 | 175,000 (Direct) |
View |
| 2023-08-31 Purchase |
2023-09-05 12:51 pm |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner |
147,991 | $26.25 | $3,884,764 | 3,714,903 (Indirect) |
View |
| 2023-08-25 Sale |
2023-08-28 4:30 pm |
Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller |
3,459 | $26.23 | $90,743 | 0 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 7:47 pm |
Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter Chief Operating Officer |
1,425 | $25.65 | $36,546 | 37,675 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 7:37 pm |
Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara Chief Development Officer |
1,004 | $25.65 | $25,749 | 105,839 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 7:35 pm |
Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela Head of Research & Development |
1,425 | $25.65 | $36,546 | 105,786 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 7:33 pm |
Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller |
915 | $25.65 | $23,467 | 5,542 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-05 7:30 pm |
Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher President and CEO |
5,498 | $25.65 | $141,005 | 316,904 (Indirect Direct) |
View |
| 2023-06-08 Sale |
2023-06-09 4:20 pm |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $29 | $423,632 | 728,732 (Indirect Direct) |
View |
| 2023-05-03 Sale |
2023-05-04 9:58 pm |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $28 | $409,024 | 743,340 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-11 Option Award |
2023-09-12 6:23 pm |
N/A 2033-09-10 |
Mirum Pharmaceuticals Inc. | MIRM | BJERKHOLT ERIC Chief Financial Officer |
165,000 | $0 | 175,000 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-05 7:33 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller |
2,605 | $0 | 5,542 (Direct) |
View |
| 2023-06-13 Other |
2023-06-15 4:36 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Walker Paul Edward 10% Owner |
2,030,114 | $0 | 2,060,228 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:35 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | SANDELL SCOTT D 10% Owner |
2,042,966 | $0 | 2,084,477 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:34 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Makhzoumi Mohamad 10% Owner |
2,041,501 | $0 | 2,082,849 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:31 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Florence Anthony A. Jr. 10% Owner |
2,041,732 | $0 | 2,083,464 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:29 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Chang Carmen 10% Owner |
2,030,135 | $0 | 2,060,270 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:28 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Behbahani Ali 10% Owner |
2,030,135 | $0 | 2,060,270 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:26 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | BASKETT FOREST 10% Owner |
2,031,548 | $0 | 2,063,096 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:24 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
2,030,000 | $0 | 4,246,243 (Indirect) |
View |
| 2023-06-13 Other |
2023-06-15 4:22 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | New Enterprise Associates 16 L.P. 10% Owner |
2,000,000 | $0 | 4,186,243 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 6:00 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Walbert Timothy P Director |
1,417 | $0 | 1,417 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:56 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Cardon Lon Director |
7,083 | $0 | 7,083 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:54 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Ramasastry Saira Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:47 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Fairey William Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:45 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Brege Laura Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:40 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Fischer Laurent Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:38 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | Heron Patrick J Director 10% Owner |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 5:35 pm |
N/A 2033-06-11 |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-09 4:20 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $2.936 | 728,732 (Direct) |
View |
| 2023-06-08 Exercise |
2023-06-09 4:20 pm |
N/A 2029-03-11 |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $0 | 728,732 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-19 4:05 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter Chief Operating Officer |
968 | $16.92 | 39,100 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-19 4:05 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara Chief Development Officer |
684 | $16.92 | 106,843 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-19 4:05 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela Head of Research & Development |
684 | $16.92 | 107,211 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-19 4:05 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher President and CEO |
1,256 | $16.92 | 322,402 (Direct) |
View |
Ownership |
2023-05-09 5:07 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | Howe Jolanda SVP, Global Controller |
0 | $0 | 234,672 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-04 9:58 pm |
N/A N/A |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $2.936 | 743,340 (Direct) |
View |
| 2023-05-03 Exercise |
2023-05-04 9:58 pm |
N/A 2029-03-11 |
Mirum Pharmaceuticals Inc. | MIRM | GREY MICHAEL G Director |
14,608 | $0 | 743,340 (Direct) |
View |
| 2023-04-05 Option Award |
2023-04-06 7:04 pm |
N/A 2033-04-04 |
Mirum Pharmaceuticals Inc. | MIRM | Walbert Timothy P Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:46 pm |
N/A 2033-01-30 |
Mirum Pharmaceuticals Inc. | MIRM | Longpre Lara Chief Development Officer |
48,125 | $0 | 144,659 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:42 pm |
N/A 2033-01-30 |
Mirum Pharmaceuticals Inc. | MIRM | Vig Pamela Head of Research & Development |
48,125 | $0 | 145,027 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:41 pm |
N/A 2033-01-30 |
Mirum Pharmaceuticals Inc. | MIRM | Radovich Peter Chief Operating Officer |
72,190 | $0 | 95,882 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 5:39 pm |
N/A 2033-01-30 |
Mirum Pharmaceuticals Inc. | MIRM | Peetz Christopher President and CEO |
250,000 | $0 | 521,146 (Direct) |
View |
| 2022-12-19 Option Award |
2022-12-19 9:26 pm |
N/A 2032-12-18 |
Mirum Pharmaceuticals Inc. | MIRM | Cardon Lon Director |
34,000 | $0 | 34,000 (Direct) |
View |